Why the study?
Do calmodulin antagonists like trifluoperazine and compound 48/80 inhibit myogenesis in chick or rat myoblast cultures?
Do calmodulin antagonists like trifluoperazine and compound 48/80 inhibit myogenesis in chick or rat myoblast cultures?
Calmodulin antagonists inhibit myoblast fusion, suggesting a role for calmodulin in the regulation of myoblast fusion but not necessarily on the appearance of muscle proteins.
Answers are grounded in this paper and cite their sources.
Calmodulin antagonists should not alter myogenesis models; leaves open species-specific roles in fusion pending in vivo studies.
When trifluoperazine (TFP), a calmodulin antagonist, was given to chick or rat myoblasts in cultures, formation of multinucleated myotubes was inhibited. The inhibition of cell fusion by TFP in rat cultures prevents the normal increase in the amount of acetylcholine receptors (AChR) and creatine kinase (CK), while the levels of these proteins in chick muscle cultures are hardly affected. Another calmodulin antagonist, compound 48/80, inhibits fusion at doses that correspond closely to its antagonistic effects on calmodulin. Thus, our results suggest a possible role for calmodulin in the regulation of myoblast fusion, but not on the appearance of muscle proteins.
No takes yet. Share an insight, caveat, or question.
Shainberg et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: